ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0922

Generation and Pathophysiological Analysis of M694I Variant Knock-in Mice of Human MEFV Gene: Insights from Single-Cell RNA Sequencing

Tomohiro Koga, Yoshika Tsuji and Atsushi Kawakami, Nagasaki University, Nagasaki, Japan

Meeting: ACR Convergence 2024

Keywords: Animal Model, Autoinflammatory diseases, cytokines, FMF, T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The primary objective of this study was to generate knock-in mice with the M694I variant of the human MEFV gene, a critical variant in the pathogenesis of familial Mediterranean fever (FMF), and analyze the resultant pathophysiological changes. Additionally, we aimed to explore the molecular mechanisms of splenocytes through single-cell RNA sequencing (scRNA-seq) and gene set enrichment analysis (GSEA).

Methods: M694I knock-in mice were generated using the CRISPR/Cas9 gene editing system. The insertion of oligo DNA was confirmed using Sanger sequencing. The study involved monitoring the survival rate and growth curves of mice, collecting peritoneal macrophages, and stimulating them with lipopolysaccharide (LPS) and ATP to analyze inflammatory responses. Flow cytometry was used to evaluate the cellular composition of the spleen, and cytokine levels were measured in serum samples. Furthermore, scRNA-seq was performed on splenocytes, followed by GSEA to identify the activated pathways in different cell populations.

Results: The M694I group exhibited a significantly lower survival rate and failure to gain weight than the wild-type (WT) group, suggesting an inflammatory pathology. Peritoneal macrophages from the M694I group showed increased activation after LPS and ATP stimulation. M694I mice showed enlarged spleens and increased splenocyte counts, indicating an abnormal immune response. Serum analysis revealed elevated G-CSF, IFN-γ, IL-6, TNF-α, and IL-5 levels in the M694I group. Notably, a significant increase in IL-17 producing cells. The M694I mutation leads to a higher percentage of IL-17 producing cells, suggesting a role in Th17 cell differentiation. Additionally, scRNA-seq and GSEA of splenocytes revealed that T cells in M694I knock-in mice exhibited increased activity of HALLMARK_INTERFERON_ALPHA_RESPONSE and HALLMARK_INTERFERON_GAMMA_RESPONSE, whereas monocytes showed elevated activity of HALLMARK_TNFA_SIGNALING_VIA_NFKB.

Conclusion: Knock-in of the MEFV gene M694I variant in mice induced chronic inflammation resembling FMF. These findings suggest that Th17 cell and cytokine dysregulation play significant roles in the pathogenesis of FMF. The M694I mouse model is a valuable tool for studying the underlying mechanisms of FMF and evaluating potential therapeutic interventions. scRNA-seq analysis provided further insights into the molecular mechanisms, highlighting the involvement of interferon responses in T cells and TNFα signaling in monocytes. Further research is needed to explore the precise pathways involved and develop targeted treatments for FMF.

Supporting image 1

The left panel shows Kaplan-Meier survival curves of WT (wild-type) and M694I knock-in mice over 20 weeks. The M694I group showed a significantly lower survival rate compared to the WT group (***p < 0.001). The right Panel shows growth curves representing the body weight of WT and M694I knock-in mice from 4 to 15 weeks of age. The M694I group exhibited significantly reduced weight gain compared to the WT group (*p < 0.05). Data are presented as mean ± SEM.


Disclosures: T. Koga: None; Y. Tsuji: None; A. Kawakami: None.

To cite this abstract in AMA style:

Koga T, Tsuji Y, Kawakami A. Generation and Pathophysiological Analysis of M694I Variant Knock-in Mice of Human MEFV Gene: Insights from Single-Cell RNA Sequencing [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/generation-and-pathophysiological-analysis-of-m694i-variant-knock-in-mice-of-human-mefv-gene-insights-from-single-cell-rna-sequencing/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/generation-and-pathophysiological-analysis-of-m694i-variant-knock-in-mice-of-human-mefv-gene-insights-from-single-cell-rna-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology